rdf:type |
|
lifeskim:mentions |
umls-concept:C0010453,
umls-concept:C0016030,
umls-concept:C0021760,
umls-concept:C0030705,
umls-concept:C0032200,
umls-concept:C0033268,
umls-concept:C0036421,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2349975,
umls-concept:C2911692
|
pubmed:issue |
8
|
pubmed:dateCreated |
1998-10-30
|
pubmed:abstractText |
The pathophysiology of systemic sclerosis (SSc) is poorly understood, but recent studies indicate the involvement of cytokines in the functional changes of SSc fibroblasts. We investigated interleukin 6 (IL-6) production by dermal fibroblasts from patients with SSc.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0315-162X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1534-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:9712097-Adult,
pubmed-meshheading:9712097-Cells, Cultured,
pubmed-meshheading:9712097-Female,
pubmed-meshheading:9712097-Fibroblasts,
pubmed-meshheading:9712097-Humans,
pubmed-meshheading:9712097-Interleukin 1 Receptor Antagonist Protein,
pubmed-meshheading:9712097-Interleukin-6,
pubmed-meshheading:9712097-Male,
pubmed-meshheading:9712097-Middle Aged,
pubmed-meshheading:9712097-Platelet-Derived Growth Factor,
pubmed-meshheading:9712097-Receptors, Platelet-Derived Growth Factor,
pubmed-meshheading:9712097-Scleroderma, Systemic,
pubmed-meshheading:9712097-Sialoglycoproteins
|
pubmed:year |
1998
|
pubmed:articleTitle |
Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor.
|
pubmed:affiliation |
Department of Rheumatology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba City, Ibaraki, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|